Patterning effects of FGF17 and cAMP on generation of dopaminergic progenitors for cell replacement therapy in Parkinson's disease
Amalie Holm Nygaard, Alrik L. Schörling, Zehra Abay-Nørgaard…·Agnete Kirkeby
This study identifies FGF17 as a potent inducer of ventral midbrain dopaminergic progenitors, which can functionally rescue motor deficits in a rat Parkinson's disease model.